Signaturefd, LLC Sangamo Therapeutics, Inc Transaction History

Signaturefd, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$1.66 - $3.67 $7,719 - $17,065	4,650 Added 39.49%	16,424 $28,000
Q4 2022 Jan 27, 2023	BUY	$2.77 - $5.07 $28,065 - $51,369	10,132 Added 617.05%	11,774 $36,000
Q3 2022 Nov 08, 2022	BUY	$4.27 - $6.39 $5,427 - $8,121	1,271 Added 342.59%	1,642 $8,000
Q2 2022 Aug 10, 2022	BUY	$3.28 - $6.21 $619 - $1,173	189 Added 103.85%	371 $2,000
Q1 2022 May 02, 2022	BUY	$5.23 - $7.82 $951 - $1,423	182 New	182 $1,000
Q2 2021 Jul 26, 2021	SELL	$10.17 - $12.64 $3,213 - $3,994	-316 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$10.88 - $17.05 $3,438 - $5,387	316 New	316 $4,000
Q3 2018 Nov 15, 2018	SELL	$13.05 - $19.05 $7,673 - $11,201	-588 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $8,173 - $11,642	588 New	588 $8,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $360M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.